Würtz M - Search Results

1

Platelet aggregation is dependent on platelet count in patients with coronary artery disease.

Würtz M, Hvas AM, Kristensen SD, Grove EL. Würtz M, et al. Thromb Res. 2012 Jan;129(1):56-61. doi: 10.1016/j.thromres.2011.08.019. Epub 2011 Sep 13. Thromb Res. 2012. PMID: 21917303

2

The antiplatelet effect of aspirin is reduced by proton pump inhibitors in patients with coronary artery disease.

Würtz M, Grove EL, Kristensen SD, Hvas AM. Würtz M, et al. Heart. 2010 Mar;96(5):368-71. doi: 10.1136/hrt.2009.181107. Epub 2009 Nov 11. Heart. 2010. PMID: 19910291 Free article.

3

Patients with previous definite stent thrombosis have a reduced antiplatelet effect of aspirin and a larger fraction of immature platelets.

Würtz M, Grove EL, Wulff LN, Kaltoft AK, Tilsted HH, Jensen LO, Hvas AM, Kristensen SD. Würtz M, et al. JACC Cardiovasc Interv. 2010 Aug;3(8):828-35. doi: 10.1016/j.jcin.2010.05.014. JACC Cardiovasc Interv. 2010. PMID: 20723855 Free article.

4

Increased platelet turnover in patients with previous definite stent thrombosis.

Grove EL, Würtz M, Hvas AM, Kristensen SD. Grove EL, et al. Among authors: wurtz m. J Thromb Haemost. 2011 Jul;9(7):1418-9. doi: 10.1111/j.1538-7836.2011.04304.x. J Thromb Haemost. 2011. PMID: 21501377 Free article. No abstract available.

5

Influence of renal function and platelet turnover on the antiplatelet effect of aspirin.

Würtz M, Wulff LN, Grove EL, Kristensen SD, Hvas AM. Würtz M, et al. Thromb Res. 2012 Apr;129(4):434-40. doi: 10.1016/j.thromres.2011.07.019. Epub 2011 Aug 11. Thromb Res. 2012. PMID: 21839494 Clinical Trial.

6

Contemporary use of glycoprotein IIb/IIIa inhibitors.

Kristensen SD, Würtz M, Grove EL, De Caterina R, Huber K, Moliterno DJ, Neumann FJ. Kristensen SD, et al. Among authors: wurtz m. Thromb Haemost. 2012 Feb;107(2):215-24. doi: 10.1160/TH11-07-0468. Epub 2012 Jan 11. Thromb Haemost. 2012. PMID: 22234385 Review.

7

Interindividual variability in the efficacy of oral antiplatelet drugs: definitions, mechanisms and clinical importance.

Würtz M, Grove EL. Würtz M, et al. Curr Pharm Des. 2012;18(33):5344-61. doi: 10.2174/138161212803251925. Curr Pharm Des. 2012. PMID: 22724409 Review.

8

Platelet function testing in atherothrombotic disease.

Grove EL, Storey RF, Würtz M. Grove EL, et al. Among authors: wurtz m. Curr Pharm Des. 2012;18(33):5379-91. doi: 10.2174/138161212803251862. Curr Pharm Des. 2012. PMID: 22724414

9

Pharmacogenetics of the antiplatelet effect of aspirin.

Würtz M, Kristensen SD, Hvas AM, Grove EL. Würtz M, et al. Curr Pharm Des. 2012;18(33):5294-308. doi: 10.2174/138161212803251907. Curr Pharm Des. 2012. PMID: 22724416 Review.

10

Combining aspirin and proton pump inhibitors: for whom the warning bell tolls?

Würtz M, Grove EL. Würtz M, et al. Expert Opin Drug Metab Toxicol. 2012 Sep;8(9):1051-5. doi: 10.1517/17425255.2012.711318. Epub 2012 Jul 27. Expert Opin Drug Metab Toxicol. 2012. PMID: 22834712

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

112 results

Search Page

Filters